作者
Madhumita Shrotri, Annalan MD Navaratnam, Vincent Nguyen, Thomas Byrne, Cyril Geismar, Ellen Fragaszy, Sarah Beale, Wing Lam Erica Fong, Parth Patel, Jana Kovar, Andrew C Hayward, Robert W Aldridge
发表日期
2021/7/31
期刊
The Lancet
卷号
398
期号
10298
页码范围
385-387
出版商
Elsevier
简介
Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to control transmission and limit morbidity and mortality due to COVID-19. Current evidence indicates strong immunogenicity and high short-term efficacy for BNT162b2 (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca).
学术搜索中的文章
M Shrotri, AMD Navaratnam, V Nguyen, T Byrne… - The Lancet, 2021